We present three cases of Neisseria meningitidis with varied clinical presentations, including meningococcemia, meningitis, and pneumonia. Our cases suggest an association between concomitant bacterial and viral infections, including group A streptococcus and adenovirus, and an increased risk of invasive Neisseria infections. Polymerase chain reaction data are a useful adjunct to bacterial cultures for the diagnosis. Our case series exemplify the continued high mortality of N. meningitides and highlights the need for more immunogenic vaccines for prevention.
Introduction
Neisseria meningitidis is a significant cause of morbidity and mortality worldwide and the leading cause of bacterial meningitis in the United States. Meningitis is the most common (80 to 85% of cases) presentation of N. meningitidis, but this Gram-negative diplococcus may also cause bacteremia, meningococcemia, or pneumonia. Uncommon presentations include pericarditis, arthritis, and conjunctivitis (1, 2) . Most cases in the United States are sporadic, although outbreaks are well described (3) (4) (5) . Infection is transmitted person-to-person via aerosol secretions; up to 10% of healthy adults have nasopharyngeal colonization. Invasive disease occurs when the organism penetrates the mucosa and gains entrance into the bloodstream, leading to systemic meningococcal disease. Risk factors for the development of clinical disease include ages of 18 to 23 years, crowded living conditions such as college dormitories or military barracks (6) , tobacco use (7), concomitant respiratory infection (8, 9) , and terminal complement deficiency (10) . We describe three cases of N. meningitidis among military members evaluated at our institution over a 1-year period. Our cases exemplify both the potential variable clinical presentation and high risk of mortality.
Case 1
An 18-year-old white/Hispanic Marine Corps recruit awoke at 3:30 a.m. with a bilateral lower extremity rash that was palpable and extremely painful. He had no previous medical diagnoses and was taking no medications. One month prior, he had arrived from northern California to the training center, at which time he received a single dose of 1.2 million units of benzathine penicillin for prophylaxis against group A streptococcus, as well as pneumococcal (polyvalent pneumovax 23, Merck & Company, Inc.) and meningococcal (Menomune quadrivalent polysaccharide vaccine, Aventis Pasteur, Inc.) vaccinations. He noted a 3-day history of cough and sore throat, but no headache or fevers. He reported to the medical clinic at 9:00 a.m., 6 hours after the rash began. He was in acute respiratory distress and reported intense myalgias. During the time of presentation, there was an ongoing outbreak of group A streptococcal pneumonia at the same training site (11) .
Vital signs showed a temperature of 98.1º F, blood pressure of 79/41 mmHg, pulse of 140 beats/minute, and respiratory rate of 36. Oxygen saturation was 84% on a 12-L oxygen nonrebreather facemask. His skin examination showed a diffuse, palpable purpuric rash consistent with purpura fulminans (Figure 1 ). Conjunctival petechiae were also noted ( Figure 2 ). Lung examination revealed tachypnea, accessory muscle use, and diffuse respiratory crackles. His heart sounds were normal except for tachycardia; there were no murmurs, rubs, or gallops.
Neurological examination was initially unremarkable with normal mental status, no nuchal rigidity, and normal strength throughout.
The differential diagnosis included meningococcemia, toxic shock syndrome, and sepsis.
Two liters of normal saline, as well as 2 g of ceftriaxone and 900 mg of clindamycin, were administered. His blood pressure increased to 122/68 mmHg, and he was transferred to our emergency room. On arrival, his systolic blood pressure was 90 mmHg, pulse 118, respiratory rate 36, and oxygen saturation 84% on 15 L of oxygen by facemask; he was intubated.
Laboratories on admission included a blood gas with a pH of 6.84, pCO 2 103, and a pO 2 of 78; the white blood cell count was 20,200 cells/ml with 85% neutrophils, hemoglobin 14.5 g/dl, and platelet count 35,000. Chemistry panel and liver function testing revealed bicarbonate of 18 mEq/L, anion gap of 15, and albumin of 2.1 g/dl; transaminases were normal. A chest radiograph showed patchy to confluent airspace opacities throughout all the visualized lobes; small biapical pneumothoraces and bilateral chest tubes were present. Cultures were unremarkable. During transfer to the intensive care unit, he became asystolic; the patient died, despite aggressive resuscitation efforts. On autopsy, he had multiple petechiae and small hemorrhages of his intestines, mesentery, renal cortex, adrenals, lungs, skeletal muscle, conjunctiva, myocardium, and epicardium ( Figure 3) . Skin was noteworthy for a purpuric rash of his face, trunk, and extremities. There was pulmonary edema, evidence of shock to multiple organs, and numerous microthrombi in the heart, lungs, liver, kidney, and brain. Vieusseux first described meningococcal disease in 1805, and the causative organism was identified in 1887 (12) (13) (14) . Worldwide, N. meningitidis accounts for 500,000 infections and 50,000 deaths annually (15) . Within the United States, the annual incidence is 0.9 to 1.5 cases per 100,000, and 98% of cases are sporadic (12) . Disease incidence is highest among infants after maternal antibodies wane and in young adults ages 15 to 23 years. Although the disease is most common in young children, case-fatality rates are highest in the teenage years. Infection occurs when virulent N. meningitidis organisms are acquired during close contact with a colonized host; the bacterium must hematogenously disseminate, while the host lacks immunity to that specific serogroup.
Risk factors for disease development include concurrent respiratory infection, which may decrease the integrity of the mucosal barrier (7, 8) . Respiratory illness may also increase the risk of N. meningitidis transmission due to increased cough and secretions (12) . Crowded living conditions, such as college dormitories and military barracks, have been associated with a heightened disease incidence (12, 16) . Among military members, military recruits have the highest risk due to crowding and arrival from diverse locations throughout the United States (6).
Other risk factors include tobacco smoke and indoor fire exposure, which likely interfere with mucosal integrity; all of our cases were in non-smoke environments.
Immunodeficiencies, including terminal complement deficiency, properdin deficiency, asplenia, and HIV infection predispose to meningococcal disease (9, 17) . Of patients with a single meningococcal infection, 5 to 10% are found to be complement C5-C9 deficient, whereas those with multiple episodes have a 30% prevalence of deficiency (18) . All patients in this case series were HIV seronegative and had normal splenic function; only one could be tested (case 2) for complement deficiency and had a normal level. None of the cases had family or personal histories remarkable for Neisseria infections or meningitis.
Other potential host factors that may play a role in susceptibility and severity of the infection include alterations of plasminogen activator inhibitor type 1, Toll-like receptor 4, Fcgamma-receptors, tumor necrosis factor α, and mannose-binding lectin (15, (19) (20) (21) . Bacterial factors are also important determinants of disease. Serogroup C is an independent predictor of death, and certain subgroups are known to be more virulent than others. A recent study of an outbreak in western Canada revealed that the circulating virulent strain was infrequently identified in the at-risk population during the outbreak (22) .
Clinical disease manifests as meningitis in 80 to 85% cases, and N. meningitidis is currently the most common cause of bacterial meningitis in the United States. Classic findings include headache, fevers, and a petechial rash that begins on the lower extremities with a predilection for areas of pressure. Blood cultures are positive in 50 to 70% of patients, and culture of petechial skin lesions have a sensitivity of nearly 70% (1). Other presentations include bacteremia without sepsis, or meningococcemia, which may occur with or without meningitis.
Early signs of meningococcemia include a petechial or purpuric rash, rigors, severe pain in the extremities, and rapid evolution of the illness (23). Meningococcemia, accounting for 10 to 20% of disease, may progress to septicemia, multiorgan system, and adrenal insufficiency (the Waterhouse-Friderichsen syndrome). Our case of meningococcemia presented with purpura fulminans, shock, and death within 8 hours of symptom development. Although there was no clinical evidence of CNS involvement, the diagnosis was confirmed by a positive PCR of the CSF.
Pneumonia occurs in 5 to 15% of cases, but is often unrecognized due to a lack of familiarity with this entity among providers. In addition, isolation of Neisseria from respiratory samples may represent pharyngeal colonization versus active infection, since 10% of healthy adults may be carriers (12) . Clinical presentation is typically cough, chills, and chest pain; a previous or concurrent upper respiratory infection is common (12) . Serogroup Y has a greater predilection to respiratory involvement (24) . Multilobar disease occurs in 40%, and mortality is reportedly rare (25) . One of our cases had a multilobar pneumonia due to N. meningitidis that Chloramphenicol is still utilized in developing countries, although resistant isolates are described Close contacts of a case of meningococcal disease should receive chemoprophylaxis with a fluoroquinolone, such as ciprofloxacin or levofloxacin, rifampin, or ceftriaxone. Disease occurrence due to failed prophylaxis from rifampin-resistant strains is described, but is rare (31) .
Index cases treated with penicillin should also be treated with a fluoroquinolone or rifampin to assure eradication of the carrier state. This is not needed for those treated with ceftriaxone. Our three cases led to the immediate prophylaxis using levofloxacin 500 mg oral tablet of persons sharing berthing areas; there were no secondary cases.
In summary, meningococcal disease has a variety of presentations, including meningitis, meningococcemia with purpura fulminans, and pneumonia. Cases may occur in all age groups, however, young adults who reside in crowded living conditions are at particular risk. Molecular techniques are a useful adjunct to bacterial cultures when commercially available. Our case series highlights the need for better preventive strategies, including novel vaccines with improved immunogenicity. 
